MicroWash has the potential to transform respiratory illness diagnostics and patient experience in a post-pandemic world. With its experienced leadership from diverse medical backgrounds and significant investments, the company is well-positioned to propel the evolution of specimen collection systems. As the demand for innovative and patient-friendly healthcare solutions continues to grow, MicroWash is poised to make a significant impact and attract further interest from both the industry and potential investors.
General Information
Get notified when MicroWash moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track MicroWash
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Health Care
About MicroWash
Taxonomy: respiratory illnesses, specimen collection, diagnostics, nasal sampling, patient experience, pandemic response, university medical devices, nasopharyngeal irrigation, precision medicine, global health crisis, telehealth, primary care
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | •••••• | 6 |
|
20 Feb 2024 |
| Pre Seed Round | •••••• | 1 |
|
20 Oct 2022 |
| Pre Seed Round | •••••• | - | 20 Oct 2022 |
MicroWash Alternatives & Competitors
Breaking down barriers to wellness while helping people feel better and breathe better.
Mobile Biospecimen Collection Services For The Medical Community
FAQ About MicroWash
Don't just browse. Track.
Signal Tracker monitors MicroWash and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.